Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Covishield booster dose: Subject Expert Committee to meet today to discuss approval

Covishield booster dose: Subject Expert Committee to meet today to discuss approval

Zee News
Friday, December 10, 2021 01:06:28 AM UTC

According to the Ministry of Health and Family Welfare, India has administered over 140 crore COVID-19 vaccine doses so far. More than 67 lakh (67,11,113) doses were administered till 7 pm on Thursday.

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday (December 10) regarding the COVID-19 booster dose, amid the government that COVID-19 vaccination coverage in the country has crossed 131 crore mark (131,09,90,768) on Thursday.

The Serum Institute of India (SII) has recently filed an application with the Drugs Controller General of India (DCGI) regarding approval for a booster dose of Covishield. It has cited that there is adequate stock of the Covid vaccine in the country now and a demand for a booster shot is there due to the emergence of new coronavirus variants, said an ANI report.

The Serum Institute is the first vaccine manufacturing company in India to apply for approval for Covishield as a booster dose.

Read full story on Zee News
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us